HT-004

N/A

Report date: 2024/04/01 15:50:15
NME

Base Information

Drug NameHT-004
Drug Alias NameHT-004
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionIgE receptors modulators
TargetsIgE receptors
Therapy Area/IndicationsAnaphylaxisAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNorth Carolina State University
China Registration ClassN/A

Develop Information

Active CompaniesHoth Therapeutics IncNorth Carolina State University
Inactive CompaniesN/A
Active IndicationsAsthma
Inactive IndicationsAnaphylaxis

Other Information

ATC CodeN/A
Related LinksN/A